Trial intelligence / Profile preview

SIMPLE Study: EnvarsusXR and Azathioprine in Kidney Transplant

NCT04773392Phase 4Terminated

Sponsor
University of Southern California
Start
Nov 2021
Primary completion
Feb 2024
Modality
RNA-Targeting Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tacrolimus in kidney transplant rejection, sponsored by University of Southern California. Started Nov 2021; status: terminated.

02

Drugs

tacrolimus
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT04773392.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04773392.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call